Advertisement Fidelity
Home > Boards > US Listed > Biotechs >

Rexahn Pharmaceuticals, Inc. (RNN)

Add RNN Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator bud_fox, beambe, Inoviorulez
Search This Board:
Last Post: 4/22/2014 7:54:39 PM - Followers: 195 - Board type: Free - Posts Today: 0


Rexahn’s goal is to be a world leader in the discovery and development of new drugs to treat cancer. By developing compounds which specifically target cancer cells, excluding healthy tissue, Rexahn’s drug candidates may demonstrate increased efficacy and reduced toxicity- efficacy against multiple drug resistant cancer cells and synergism with existing cytotoxic compounds. Utilizing a powerful, multi-faceted discovery engine consisting of small signaling molecule discovery, computational modeling, nanotechnology-based drug targeting and delivery, we believe that we are well on our way to achieving our goal.

Rexahn’s core scientific expertise in the understanding of signal transduction processes involved in cancer cell growth is producing a drug portfolio with significant potential clinical value.

Today, our clinical development pipeline consists of three novel compounds:

Archexin® (Phase IIa) a best-in-class compound that blocks both the activated and native forms of Akt1 and has FDA orphan drug designation for the treatment of pancreatic cancer, ovarian cancer, stomach cancer, RCC, and glioblastoma.

RX-3117 (Phase I) a best-in-class compound that inhibits DNA and RNA synthesis, and exhibits high oral bioavailability. In comparison, RX-3117 may have a better safety profile than gemcitabine, the current first-line therapy for pancreatic and other cancers.

SupinoxinTM (RX-5902) (Phase I) a first-in-class small molecule that inhibits the phosphorylated p68 RNA helicase, a protein that plays a key role in cancer growth, progression and metastasis.

These lead clinical drugs are part of a growing oncology drug pipeline that consists of highly differentiated and exciting anti-cancer compounds.

Our strategy is to continue building a significant product pipeline of innovative medicines that we will commercialize on our own or with other pharmaceutical partners. Rexahn’s powerful discovery engine and differentiated product pipeline provide the opportunity for a high value generating biopharmaceutical company- one with the expertise to develop cures for significant diseases of our time.

Rexahn Pipeline


Management Team

Peter Suzdak, Ph.D.
Chief Executive Officer

Dr. Peter Suzdak joined Rexahn Pharmaceuticals in February 2013. Dr. Suzdak has over 25 years of diverse experience, including several management positions, in the pharmaceutical industry. Most recently, Dr. Suzdak was Chief Scientific Officer of Corridor Pharmaceuticals, a company developing small molecule compounds to treat pulmonary and vascular disorders. Prior to Corridor Pharmacueitcals, he was co-Founder, Chief Executive Officer and Chief Scientific Officer of Cardioxyl Pharmaceuticals, a company focused on therapies for the treatment of cardiovascular disease. Previous to Cardioxyl Pharmaceuticals, he was President and Chief Executive Officer of Artesian Therapeutics, a company engaged in the development of small molecule therapeutics for cardiovascular diseases. Dr. Suzdak’s experience also includes his position as Senior Vice President of Research and Development of Guilford Pharmaceuticals, a company that developed therapeutics and diagnostics for neurological diseases and cancer, and as Director of Neurobiology for Novo Nordisk. Dr. Suzdak holds a Ph.D. in pharmacology and toxicology from the University of Connecticut.

Rick Soni, MBA
President and Chief Operating Officer

Rick Soni joined Rexahn in 2008 with over 20 years of sales, marketing, product planning and business development experience in the pharmaceutical industry. Prior to joining Rexahn, Mr. Soni held leadership roles at Otsuka America Pharmaceuticals, Inc., with responsibility for commercial development, corporate strategy and execution of licensing and acquisition of therapeutics, diagnostics and medical devices. Previously, Mr. Soni has held a variety of management positions at Novartis and Schering-Plough. Mr. Soni has a BS from the University of Wisconsin-Madison and an MBA from Fairleigh Dickinson University.

Tae Heum (Ted) Jeong, D. Mgt.
Sr. Vice President  and Chief Financial Officer

Dr. Jeong has been Chief Financial Officer of Rexahn Pharmaceuticals since 2002. He oversees all aspects of capital raising, accounting, operations, and corporate development for Rexahn. He is also responsible for investor relations, and played a key role in Rexahn’s 2008 listing on the New York Stock Exchange (NYSE) AMEX. For the past 16 years, he has extensive experience in venture capital and investment banking industry that includes role at Hyundai Venture Investment Corporation where he managed the Biotechnology investment team. Dr. Jeong holds a Doctor of Management from University of Maryland and an M.S. in Finance from Johns Hopkins University

Roth Capital Partners, LLC
   Joseph Pantginis, Ph.D.

Maxim Group, LLC
Echo He, MD, Ph.D.

H. C. Wainwright & Co., LLC
Andrew Fein

Tricia Truehart
(646) 378-2953

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
RNN News: Rexahn Presents Data from Preclinical Studies of RX-21101 04/21/2014 09:00:00 AM
RNN News: Proxy Statement (definitive) (def 14a) 04/18/2014 04:16:32 PM
RNN News: Statement of Changes in Beneficial Ownership (4) 04/16/2014 04:19:21 PM
RNN News: Brinson Patrick Re-launches Research Department 04/10/2014 08:21:00 AM
RNN News: Rexahn Pharmaceuticals to Present Data on RX-3117 & RX-21101 at the 2014 American Association for Clinical Research Annual Me... 04/02/2014 09:00:00 AM
#2536   Nice to c u back bud. It would ttubular 04/22/14 07:54:39 PM
#2535   Charts shaping up. Need confirmation. Showing signs of bud_fox 04/21/14 10:43:09 PM
#2534   Finished up .02c and held 1.00 bullish IMO bubbacon 04/21/14 06:49:33 PM
#2533   Nice News Packardbell 04/21/14 03:12:42 PM
#2532   5 CENTS? THAT'S ALL WE GET? BS skydog526 04/21/14 11:12:56 AM
#2531   Rexahn Presents Data from Preclinical Studies of RX-21101 Proprietary BlueDragon 04/21/14 09:33:07 AM
#2530   News out... Lilpunch01 04/21/14 09:12:42 AM
#2529   Reverse split on its way (to be voted boldcab 04/21/14 07:59:30 AM
#2528   Click on my handle General and look at eventhelosers 04/17/14 10:17:41 AM
#2527   Yes. Compared to the MJ sector. I hate GeneralLee 04/17/14 10:00:26 AM
#2526   Yes sir, I'm in another biotech with drugs eventhelosers 04/17/14 08:52:23 AM
#2525   Put it in the closet and forget about GeneralLee 04/16/14 04:42:30 PM
#2524   This will fly to above 5 dollars, when, eventhelosers 04/16/14 02:04:03 PM
#2523   I have balls of steel. Held on yesterday skydog526 04/16/14 02:01:12 PM
#2522   Hey there, you n I were playing with eventhelosers 04/16/14 01:38:53 PM
#2520   No Bad News ;-) come good News Packardbell 04/15/14 05:26:16 PM
#2519   Down day like this?? Bad news coming, really Green29 04/15/14 12:25:27 PM
#2518   I guess the current PPS puts us on GeneralLee 04/15/14 11:53:23 AM
#2517   Oh Jesus the support was blown thru like nathan2123 04/15/14 11:10:38 AM
#2516   RNN in at .76 BlackOpStocks 04/15/14 10:52:00 AM
#2515   Shakedown! DorianGray 04/15/14 10:51:39 AM
#2514   Bounce! JDV57 04/15/14 10:47:58 AM
#2513   one word... BRUTAL erik007tc 04/15/14 10:46:09 AM
#2512   Markets have the appearance of sell all risk DorianGray 04/15/14 10:22:43 AM
#2511   Did I miss something? DorianGray 04/15/14 10:18:44 AM
#2510   Why the dump today? AnG5640 04/15/14 10:07:57 AM
#2509   Thanks Nathan dustfinder 04/15/14 09:34:02 AM
#2508   Not far we got good support at the nathan2123 04/15/14 09:28:09 AM
#2507   Bud how far do you think RNN will fall. dustfinder 04/15/14 08:58:09 AM
#2506   I thought I said that the Money Flow bud_fox 04/14/14 08:01:12 PM
#2505   Lol bubbacon 04/14/14 06:37:00 PM
#2504   Great call bud the POS hit .98 cent's today! skydog526 04/14/14 03:41:28 PM
#2503   Nice to c u back bud ttubular 04/13/14 04:22:03 PM
#2502   MFI is at 40.32 and turning positive. Once bud_fox 04/13/14 12:42:52 AM
#2501   Question is are you going to sell? beenzoot 04/11/14 07:26:59 PM
#2500   Everyone a bag holder now. Wtf skydog526 04/11/14 04:04:50 PM
#2499   RNN....dilution??? cooljet 04/11/14 03:18:52 PM
#2497   RNN Analysis - SelfMadeMillionaire 04/10/14 12:14:25 AM
#2496   Thanks. This is a good read and summarizes beenzoot 04/09/14 10:30:49 PM
#2495   This is a West Coast program: GeneralLee 04/09/14 04:29:57 PM
#2494   Awaiting news like everyone else. Slow and steady GeneralLee 04/09/14 04:27:49 PM
#2493   HELLO? skydog526 04/09/14 03:51:18 PM
#2492   Where is everyone ttubular 04/09/14 12:13:56 PM
#2491   Nice find thanks Bro GeneralLee 04/04/14 04:23:20 PM
#2490   i added all i could on this dip the_little_farmer 04/04/14 03:13:36 PM
#2489   you are welcome bud and be ready for the_little_farmer 04/04/14 03:11:45 PM
#2488   Thank you. 2bStealthy 04/04/14 03:10:12 PM
#2487   enjoy this guys :) the_little_farmer 04/04/14 02:56:02 PM
#2486   I should probably have sold today. I'm sure skydog526 04/04/14 02:37:25 PM
#2485   Like Jim said "push on thru to the dustfinder 04/04/14 11:17:41 AM